Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP718427.RA-eUNsRF4oR5LFd0a7OHgo8uOlOxvWk2AbVfnaN6UNOg130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP718427.RA-eUNsRF4oR5LFd0a7OHgo8uOlOxvWk2AbVfnaN6UNOg130_assertion type Assertion NP718427.RA-eUNsRF4oR5LFd0a7OHgo8uOlOxvWk2AbVfnaN6UNOg130_head.
- NP718427.RA-eUNsRF4oR5LFd0a7OHgo8uOlOxvWk2AbVfnaN6UNOg130_assertion description "[Phase 1 trial of allogeneic gene-modified tumor cell vaccine RCC-26/CD80/IL-2 in patients with metastatic renal cell carcinoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP718427.RA-eUNsRF4oR5LFd0a7OHgo8uOlOxvWk2AbVfnaN6UNOg130_provenance.
- NP718427.RA-eUNsRF4oR5LFd0a7OHgo8uOlOxvWk2AbVfnaN6UNOg130_assertion evidence source_evidence_literature NP718427.RA-eUNsRF4oR5LFd0a7OHgo8uOlOxvWk2AbVfnaN6UNOg130_provenance.
- NP718427.RA-eUNsRF4oR5LFd0a7OHgo8uOlOxvWk2AbVfnaN6UNOg130_assertion SIO_000772 19788391 NP718427.RA-eUNsRF4oR5LFd0a7OHgo8uOlOxvWk2AbVfnaN6UNOg130_provenance.
- NP718427.RA-eUNsRF4oR5LFd0a7OHgo8uOlOxvWk2AbVfnaN6UNOg130_assertion wasDerivedFrom befree-20140225 NP718427.RA-eUNsRF4oR5LFd0a7OHgo8uOlOxvWk2AbVfnaN6UNOg130_provenance.
- NP718427.RA-eUNsRF4oR5LFd0a7OHgo8uOlOxvWk2AbVfnaN6UNOg130_assertion wasGeneratedBy ECO_0000203 NP718427.RA-eUNsRF4oR5LFd0a7OHgo8uOlOxvWk2AbVfnaN6UNOg130_provenance.